128 filings
8-K
PBLA
Panbela Therapeutics, Inc.
25 Apr 24
Entry into a Material Definitive Agreement
4:35pm
8-K
PBLA
Panbela Therapeutics, Inc.
22 Apr 24
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
8:02am
8-K
PBLA
Panbela Therapeutics, Inc.
17 Apr 24
Panbela Announces Transfer to OTCQB Market
8:36am
8-K
PBLA
Panbela Therapeutics, Inc.
26 Mar 24
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
4:12pm
8-K
PBLA
Panbela Therapeutics, Inc.
7 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:01am
8-K
txiluchvk mzcac4
15 Feb 24
Regulation FD Disclosure
8:05am
8-K
q0aoc9c61wu62tyepet
13 Feb 24
Departure of Directors or Certain Officers
5:24pm
8-K
ojxlak yn
1 Feb 24
Panbela Announces Closing of Approximately $9.0 Million Public Offering
7:15am
8-K
xpfkn1
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am
8-K
v3gepy8qde2g4egt6yb
25 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
14p6uiw2qp4lmsccf1z
19 Jan 24
Material Modifications to Rights of Security Holders
5:20pm
8-K
qwgiosd3iplrsy
21 Dec 23
Entry into a Material Definitive Agreement
9:25am
8-K
ut741
21 Dec 23
Submission of Matters to a Vote of Security Holders
6:00am
8-K
rv9d79ok6380qx88
1 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
c7wx xe5xgsk3uj8
9 Nov 23
Panbela Provides Business Update and Reports Q3 2023 Financial Results
4:10pm
8-K
edq0to4xh4y0ceag36
3 Nov 23
Entry into a Material Definitive Agreement
5:24pm
8-K
6gul cha1
10 Aug 23
Panbela Provides Business Update and Reports Q2 2023 Financial Results
4:11pm
8-K
53f1em5ej2krcxr
19 Jul 23
Regulation FD Disclosure
8:02am
8-K
x5hx czgfzf
10 Jul 23
Regulation FD Disclosure
4:15pm
8-K
8shcigh818fg 62dsi
21 Jun 23
Panbela Announces Pricing of Approximately $8.5 Million Public Offering
5:00pm